Navigation Links
Stiefel Laboratories Announces the Expansion of Its REVALESKIN(R) Skin Care Line With Three New Products

Clinically Proven, Anti-Aging REVALESKIN(R) Skin Care Brand Launches New REVALESKIN(R) Replenishing Eye Therapy, REVALESKIN(R)Intense Recovery Treatment and REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment, All Exclusively Formulated With the Naturally Potent, Super-Antioxidant CoffeeBerry(R) Extract

CORAL GABLES, Fla., Dec. 4 /PRNewswire/ -- - On the heels of the extraordinarily successful introduction of the core REVALESKIN(R) skin care system (Facial Cleanser, Day Cream with SPF 15 sunscreen and Night Cream), Stiefel Laboratories announces the expansion of its REVALESKIN skin care line with three new products.

"Demand for the core REVALESKIN(R) skin care system has been overwhelming, and we are pleased to bring to market additional quality aesthetic offerings to augment the line," said William D. Humphries, president, Stiefel Laboratories, Inc. "Specifically, we are excited to announce the launch of REVALESKIN(R) Replenishing Eye Therapy, REVALESKIN(R) Intense Recovery Treatment for extremely dry/damaged or post-procedure skin and REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment, formulated for the neck and chest areas."

According to a Global Industry Analysis Report (March 2008), the market for anti-aging products is predicted to reach $115.5 billion by 2010. With the launch of these three new products, the REVALESKIN(R) skin care line will meet consumer demand for professional take-home beauty products designed for targeted treatment of problem skin areas.

The REVALESKIN(R) skin care line is the first and only physician-dispensed line of skin care products exclusively formulated with the naturally potent super-antioxidant CoffeeBerry(R) extract. Clinically proven to improve the skin's appearance in as few as 11 days, REVALESKIN(R) skin care products have been shown to provide significant improvements in overall skin appearance, including a reduction in the appearance of fine lines, wrinkles, pigmentation and redness. Manufactured and marketed by Stiefel Laboratories, Inc., all REVALESKIN(R) skin care products are available only through aesthetic physicians' offices nationwide.

REVALESKIN(R)Replenishing Eye Therapy

The demand was so high before its launch in August 2008 that REVALESKIN(R) Replenishing Eye Therapy with 1% CoffeeBerry(R) extract actually had a waiting list. Formulated with caffeine and natural antioxidant extracts, the eye therapy gently yet deeply penetrates eye-area skin and moisturizes, rejuvenates and reduces puffiness around the eyes.

REVALESKIN(R) Replenishing Eye Therapy also contains "interference pearls," mica and silica, that have been shown to reflect light and minimize the appearance of fine lines and wrinkles.

Gentle enough to use daily, in the morning under REVALESKIN(R) Day Cream and at night under REVALESKIN(R) Night Cream, REVALESKIN(R) Replenishing Eye Therapy protects the delicate eye area and improves skin elasticity, brightness and firmness.

In a recent clinical study conducted by New York City dermatologist Suzanne Friedler, M.D., F.A.A.D., of Advanced Dermatology P.C. and The Center for Laser and Cosmetic Surgery, approximately 30 participants applied REVALESKIN(R) Replenishing Eye Therapy to the eye area twice a day for 8 weeks. The appearance of fine lines and wrinkles was reduced by 26 percent in women with visible crow's feet. In addition, the appearance of redness and pigmentation were reduced by more than 44 percent and dryness and roughness by nearly 70 percent. More than 80 percent of study participants agreed that puffiness, fine lines/wrinkles, softness/smoothness and overall appearance of the eye area were significantly improved with REVALESKIN(R) Replenishing Eye Therapy.

Available now, REVALESKIN(R) Replenishing Eye Therapy is sold exclusively through aesthetic physicians' offices nationwide and retails for $80.

REVALESKIN(R) Intense Recovery Treatment

REVALESKIN(R) Intense Recovery Treatment will hit aesthetic physicians' offices in early 2009. Specially formulated with 1.5% CoffeeBerry(R) extract, the highest concentration available in skin care, REVALESKIN(R) Intense Recovery Treatment provides a solution for dry, damaged and post-procedure skin. Nonirritating and ideal for all skin types, REVALESKIN(R) Intense Recovery Treatment is suitable for everyday rejuvenation or whenever skin needs an extra boost.

Sponsored by Stiefel Laboratories, Inc., clinical studies conducted simultaneous with product launch will show that the 1.5% CoffeeBerry(R) extract formulation of REVALESKIN(R) Intense Recovery Treatment fosters a shorter recovery time and helps to restore and protect skin after noninvasive cosmetic procedures.

REVALESKIN(R) Intense Recovery Treatment with 1.5% CoffeeBerry(R) extractwill be sold exclusively through aesthetic physicians' offices nationwide and will retail for $130.

REVALESKIN(R)Chest/Decolletage Rejuvenating Treatment

Scheduled to launch in 2009, REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment actively conditions and improves the appearance of exposed skin on delicate chest and neck areas. This moisturizing repair formulation, with 1% CoffeeBerry(R) extract and phenylethyl resorcinol, a skin-lightening agent, works to even skin tone, restore suppleness and minimize the appearance of photo aging with the naturally potent super antioxidant CoffeeBerry(R) extract.

REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment also contains the "interference pearls" mica and silica, which have been shown to reflect light and minimize the appearance of fine lines and wrinkles.

Clinical studies for REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment are being conducted to show reduced appearance of fine lines, wrinkles, freckles and pigmentation on the chest and neck.

REVALESKIN(R) Chest/Decolletage Rejuvenating Treatment will be sold exclusively through aesthetic physicians' offices nationwide and will retail for $120.

What Is CoffeeBerry(R)Extract?

A product of Coffea arabica plants, CoffeeBerry(R) extract is derived from the whole coffee fruit. When the whole coffee fruit is harvested at a sub-ripe stage, antioxidants are at their peak. After harvest, the antioxidant rich whole sub-ripe coffee cherry is processed to produce CoffeeBerry(R) extract

Four key polyphenols -- chlorogenic acid, condensed proanthocyanidins, quinic acid and ferulic acid -- contribute to the super-antioxidant potency of CoffeeBerry(R) extract, which drastically outperforms other commonly known natural antioxidants like green tea, pomegranate, vitamin C and vitamin E on the U.S. Department of Agriculture's Oxygen Radical Absorbance Capacity (ORAC) scale.

About the REVALESKIN(R) Skin Care System

The REVALESKIN(R) skin care system is the first and only physician-dispensed line of skin care products exclusively formulated with the naturally potent super-antioxidant CoffeeBerry(R) extract. The core REVALESKIN(R) skin care system includes REVALESKIN(R) Day Cream with SPF 15 sunscreen and REVALESKIN(R) Night Cream, both with 1% CoffeeBerry(R) extract, and REVALESKIN(R) Facial Cleanser with 0.1% CoffeeBerry(R) extract. All REVALESKIN(R) skin care products are noncomedogenic, allergy-tested, dermatologist-tested and suitable for everyday use.

Since launch, REVALESKIN(R) skin care products have been vastly covered in both professional and consumer media. Most recently, the October 2008 issue of Allure, the nation's premier consumer beauty magazine, recognized REVALESKIN(R) Night Cream as a "Best of Beauty" award winner.

For more information about the REVALESKIN(R) skin care line or to find out where to purchase REVALESKIN(R) skin care products in your area, talk to your aesthetic physician or visit

About Stiefel Laboratories, Inc.

Stiefel Laboratories is enthusiastically committed to advancing dermatology and skin science around the world. The company's deeply-rooted dedication and drive for innovation along, with its sole focus on dermatology, has led Stiefel to become the largest independent dermatology company in the world. In addition to more than 30 wholly-owned subsidiaries, six manufacturing plants and a global research and development network, Stiefel's most valuable asset is its global network of nearly 4,000 driven associates.

By combining expertise, knowledge and imagination, Stiefel delivers exceptional ethical, over-the-counter and aesthetic products to its customers in more than 100 countries around the world, ultimately providing a unique Stiefel skin health experience. Stiefel also is committed to improving today's treatments and exploring tomorrow's innovations. Each year, the company invests more than $100 million USD in developing the most advanced skin health solutions. Additionally, Stiefel supplements its research and development efforts by seeking strategic partnerships and acquisitions around the world. To learn more about Stiefel, visit

REVALESKIN, REVALESKIN & Design, STIEFEL and STIEFEL & Design are registered trademarks of Stiefel Laboratories, Inc. The CoffeeBerry(R) trademark and related US and international patents pending are owned by VDF FutureCeuticals, Inc., and exclusively licensed by J&J Technologies, LC.

(C) 2008 Stiefel Laboratories, Inc. All rights reserved.

SOURCE Stiefel Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stiefel Laboratories, Inc. Appoints New President
2. Stiefel Laboratories Appoints First Chief Scientific Officer
3. Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
4. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
5. Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
10. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
11. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
Post Your Comments:
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, ... The new Q-Suite 6 platform is based on the latest Java Enterprise standards. By ... piece of software for many key components of the suite. Much of the suite ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the ... several models of traditional and far-infrared saunas. , For traditional saunas, Finnleo ... most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic White ...
(Date:11/25/2015)... (PRWEB) , ... November 26, 2015 , ... ... Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and ... Office in Nairobi (UNON) for the opening of the 5th African Network for ...
(Date:11/25/2015)... Jacksonville, FL (PRWEB) , ... November 25, 2015 ... ... treatment center, is encouraging people across the country to celebrate their sobriety and ... invites people to post “before and after” photos this Thanksgiving with the hashtag ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm ... appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto ... Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... -- Research and Markets ( ) has announced ... by Type (Dressings, Therapy Devices, Active Wound Care), Application ... and Geography - Global Forecast to 2020" report ... --> The purpose of this report is ... global advanced wound care market. It involves deep dive ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... 2015  The American Academy of Pediatrics (AAP), ... the March of Dimes cheered today,s signature into ... Act of 2015 (S.799), which takes much-needed ... exposed to drugs, such as opioids, and to ... three organizations have worked together leading advocacy efforts ...
Breaking Medicine Technology: